Harrison M S, Simonte S J, Kauffman C A
Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.
Clin Infect Dis. 1994 Sep;19(3):431-4. doi: 10.1093/clinids/19.3.431.
We report the case of a 41-year-old man infected with human immunodeficiency virus who had two episodes of aseptic meningitis that occurred 2 weeks apart; the first was associated with ingestion of trimethoprim-sulfamethoxazole (TMP-SMZ) and the second was associated with ingestion of TMP alone. Onset of fever, headache, and flushing was abrupt, followed by somnolence, hearing loss, and aphasia. Analysis of the CSF showed pleocytosis and an elevated protein level. The findings resolved within 48 hours after withdrawal of the drug. We also review 18 previously reported cases of TMP-SMZ- or TMP-induced meningitis, 17 of which occurred in women. In all of these cases, a similar abrupt onset and resolution were noted. Six of the 18 patients had collagen-vascular diseases. All but two of these patients had multiple recurrent episodes of meningitis before the diagnosis was made. We conclude that the diagnosis of TMP-SMZ- or TMP-induced meningitis should be considered when a patient receiving these drugs has recurrent episodes of aseptic meningitis.
我们报告了一例41岁感染人类免疫缺陷病毒的男性病例,该患者出现了两次无菌性脑膜炎发作,间隔2周;第一次发作与服用复方新诺明(TMP-SMZ)有关,第二次发作仅与服用甲氧苄啶(TMP)有关。发热、头痛和潮红起病突然,随后出现嗜睡、听力丧失和失语。脑脊液分析显示细胞增多和蛋白水平升高。停药后48小时内症状缓解。我们还回顾了18例先前报道的由TMP-SMZ或TMP引起的脑膜炎病例,其中17例发生在女性身上。在所有这些病例中,均观察到类似的突然起病和缓解情况。18例患者中有6例患有胶原血管病。除2例患者外,所有这些患者在确诊前均有多次复发性脑膜炎发作。我们得出结论,当接受这些药物治疗的患者反复出现无菌性脑膜炎发作时,应考虑TMP-SMZ或TMP引起的脑膜炎的诊断。